Dineli Wickramsinghe, Ph.D.


Dr. Dineli Wickramasinghe has over 20 years of biotech industry experience. Currently as founding partner at DWSO Biopharma Consulting, she advises venture capital firms, investors, biotech startups, biopharma executive leadership and review boards.
Previously, Dr. Wickramasinghe was Chief Scientific Officer at Affinita Biosciences and site head at Amgen San Francisco. She led Translational and Oncology Research at 23andMe and Amgen San Francisco respectively, developing both protein and small molecule therapeutics. Prior to that, she led oncology teams at Genentech and BASF BioResearch, while also serving as adjunct faculty and post-doc mentor.

Dr. Wickramasinghe has a B.A. from Mount Holyoke College in Massachusetts and a Ph.D. from Tufts University in Boston. She completed her post-doctoral fellowship in molecular genetics at the National Cancer Institute in Maryland. She has authored numerous peer reviewed scientific publications, book reviews and presented at national and international conferences, in addition to being an inventor on multiple patents.

Go to Top